Half-year report · Q2

Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥11.7bn2024-06-01 → 2024-11-30Cons.Net sales
Revenue¥22.7bn2023-06-01 → 2024-05-31Cons.Net sales (5-year summary)
Revenue¥11.2bn2023-06-01 → 2023-11-30Cons.Net sales
Operating income¥879m2024-06-01 → 2024-11-30Cons.Operating income
Operating income¥631m2023-06-01 → 2023-11-30Cons.Operating income
Ordinary income¥906m2024-06-01 → 2024-11-30Cons.Ordinary income
Ordinary income¥1.5bn2023-06-01 → 2024-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥625m2023-06-01 → 2023-11-30Cons.Ordinary income
Profit before tax¥906m2024-06-01 → 2024-11-30Cons.Income before income taxes
Profit before tax−¥53m2023-06-01 → 2023-11-30Cons.Income before income taxes
Net income (owners)¥608m2024-06-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥706m2023-06-01 → 2024-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥120m2023-06-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income¥608m2024-06-01 → 2024-11-30Cons.Profit loss
Net income¥124m2023-06-01 → 2023-11-30Cons.Profit loss
Total assets¥23.3bnat 2024-11-30Cons.Assets
Total assets¥22.7bnat 2024-05-31Cons.Assets
Total assets¥23.6bnat 2023-11-30Cons.Total assets (5-year summary)
Total liabilities¥9.5bnat 2024-11-30Cons.Liabilities
Total liabilities¥9.4bnat 2024-05-31Cons.Liabilities
Net assets / equity¥13.8bnat 2024-11-30Cons.Net assets
Net assets / equity¥13.4bnat 2024-05-31Cons.Net assets
Net assets / equity¥13.0bnat 2023-11-30Cons.Net assets (5-year summary)
Cash and deposits¥6.7bnat 2024-11-30Cons.Cash and deposits
Cash and deposits¥7.0bnat 2024-05-31Cons.Cash and deposits
Cash & equivalents¥6.3bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥6.9bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.7bnat 2023-05-31dCons.Cash and cash equivalents
Operating cash flow¥310m2024-06-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥449m2023-06-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥358m2024-06-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Investing cash flow¥102m2023-06-01 → 2024-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥270m2023-06-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥425m2024-06-01 → 2024-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.4bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥603m2023-06-01 → 2023-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥103.032024-06-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥119.582023-06-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.372023-06-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio59.4%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio58.9%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥11.0bn
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥11.0bn
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥731m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentrevenue2024-06-01 → 2024-11-30¥671m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentrevenue external2024-06-01 → 2024-11-30¥671m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentsegment profit2024-06-01 → 2024-11-30¥148m
—segment totalrevenue2024-06-01 → 2024-11-30¥11.7bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥11.7bn
—segment totalsegment profit2024-06-01 → 2024-11-30¥879m
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥10.5bn
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥10.5bn
jpcrp040300-q2r_E00890-000Chemical Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥579m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥693m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥693m
jpcrp040300-q2r_E00890-000Healthcare Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥52m
—segment totalrevenue2023-06-01 → 2023-11-30¥11.2bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥11.2bn
—segment totalsegment profit2023-06-01 → 2023-11-30¥631m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 481
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant1518245000JPY
Net defined benefit liabilityCurrentQuarterInstant1496704000JPY
Other nclPrior1YearInstant180821000JPY
Other nclCurrentQuarterInstant156718000JPY
Noncurrent liabilitiesPrior1YearInstant3643521000JPY
Noncurrent liabilitiesCurrentQuarterInstant3332088000JPY
LiabilitiesPrior1YearInstant9356408000JPY
LiabilitiesCurrentQuarterInstant9451008000JPY
Capital stockPrior1YearInstant585199000JPY
Capital stockCurrentQuarterInstant585199000JPY
Capital surplusPrior1YearInstant614278000JPY
Capital surplusCurrentQuarterInstant614278000JPY
Retained earningsPrior1YearInstant11762265000JPY
Retained earningsCurrentQuarterInstant12240630000JPY
Treasury stockPrior1YearInstant-51249000JPY
Treasury stockCurrentQuarterInstant-51249000JPY
Shareholders equityPrior1YearInstant12910494000JPY
Shareholders equityCurrentQuarterInstant13388860000JPY
Valuation difference on available for sale securitiesPrior1YearInstant132188000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant132792000JPY
Foreign currency translation adjustmentPrior1YearInstant342481000JPY
Foreign currency translation adjustmentCurrentQuarterInstant321815000JPY
Valuation and translation adjustmentsPrior1YearInstant474670000JPY
Valuation and translation adjustmentsCurrentQuarterInstant454608000JPY
Net assetsPrior1YearInstant13385165000JPY
Net assetsCurrentQuarterInstant13843468000JPY
Liabilities and net assetsPrior1YearInstant22741573000JPY
Liabilities and net assetsCurrentQuarterInstant23294476000JPY
Net salesPrior1YTDDuration11228000000JPY
Net salesCurrentYTDDuration11691076000JPY
Cost of salesPrior1YTDDuration7249629000JPY
Cost of salesCurrentYTDDuration7403945000JPY
Gross profitPrior1YTDDuration3978370000JPY
Gross profitCurrentYTDDuration4287131000JPY
Selling general and administrative expensesPrior1YTDDuration3347533000JPY
Selling general and administrative expensesCurrentYTDDuration3408476000JPY
Operating incomePrior1YTDDuration630837000JPY
Operating incomeCurrentYTDDuration878654000JPY
Interest income noiPrior1YTDDuration3545000JPY
Interest income noiCurrentYTDDuration4092000JPY
Dividends income noiPrior1YTDDuration5934000JPY
Dividends income noiCurrentYTDDuration8141000JPY
Rent income noiPrior1YTDDuration22118000JPY
Rent income noiCurrentYTDDuration22145000JPY
Other noiPrior1YTDDuration11133000JPY
Other noiCurrentYTDDuration13138000JPY
Non operating incomePrior1YTDDuration42731000JPY
Non operating incomeCurrentYTDDuration47517000JPY
Interest expenses noePrior1YTDDuration5052000JPY
Interest expenses noeCurrentYTDDuration3496000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-05-31pass
balance sheet identityconsolidated 2024-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2023-06-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2024-06-01/2024-11-30pass
statement vs summary · revenueconsolidated 2023-06-01/2023-11-30pass
statement vs summary · revenueconsolidated 2024-06-01/2024-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass
statement vs summary · total assetsconsolidated 2024-11-30pass